Helicobacter pylori and Epstein-Barr Virus Co-Infection in Polish Patients with Gastric Cancer - A Pilot Study

Pol J Microbiol. 2022 Feb 27;71(1):123-129. doi: 10.33073/pjm-2022-004.

Abstract

The infectious agents may be the etiological factor of up to 15-20% of cancers. In stomach cancer, attention is paid to Helicobacter pylori and Epstein-Barr virus, both of which cause gastritis and can lead to tumor development. In co-infection, the inflammatory process is much more intense. We assessed the seroprevalence towards H. pylori and EBV in 32 patients with diagnosed gastric cancer. H. pylori antibodies were found in 69% patients, and anti-EBV - in all of them. The study confirmed that co-infection of H. pylori and EBV seems to be important in etiopathology of gastric cancer.

Keywords: EBV; Helicobacter pylori prevalence; co-infection; gastric cancer; infection agents in cancer.

MeSH terms

  • Antibodies, Bacterial
  • Coinfection* / epidemiology
  • Epstein-Barr Virus Infections* / complications
  • Epstein-Barr Virus Infections* / epidemiology
  • Helicobacter Infections* / complications
  • Helicobacter Infections* / epidemiology
  • Helicobacter pylori*
  • Herpesvirus 4, Human
  • Humans
  • Pilot Projects
  • Poland / epidemiology
  • Seroepidemiologic Studies
  • Stomach Neoplasms* / epidemiology
  • Stomach Neoplasms* / pathology

Substances

  • Antibodies, Bacterial